Companies Responsible for Disclosure of Pharmacoeconomic Data: Chairman Eiki of Bayer Yakuhin

In a lecture at the Regulatory Science Symposium sponsored by Thomson Reuters on September 1 in Tokyo, Norikazu Eiki, chairman of Bayer Yakuhin, expressed his opinion, saying that pharmaceutical companies should collect pharmacoeconomic data through the clinical trials of new...read more